Gilteritinib Results in Higher Remission and Transplant Rates Than Midostaurin but Does Not Increase the Post-Induction Mutational MRD Negative Rate: Results of the Phase 2 Randomized Precog 0905 Study in Newly Diagnosed FLT3 Mutated AML
医学
内科学
肿瘤科
诱导疗法
化疗
作者
Selina M. Luger,Li Chen,Keith W. Pratz,Sanam Loghavi,Alexander E. Perl,Jessica K. Altman,Robert L. Redner,Amir T. Fathi,Ayman Qasrawi,Adam S. Asch,Deepa Jeyakumar,James M. Foran,Mithun Vinod Shah,Jonathan E. Kolitz,Ellin Berman,Lindsay Wilde,Sameem Abedin,Vamsi Kota,Krishna Gundabolu,Kristen M. O’Dwyer
PDF的下载单位、IP信息已删除
小花排草
不想干活
飲啖茶食個包
曾天祥
HZQ
Serendipity
畅快的紫烟
积极从蕾
打卡下班
范星月
核桃
xzy998
eric888
昏睡的蟠桃
开朗穆
风清扬
pluto
iNk
Wind
鸣笛
皖公网安备34019202002308
